遵循指南® - AFIB 识别条件
Hospitals that participate actively and consistently in 遵循指南®- AFIB are eligible for public recognition. Participating in GWTG-AFIB is the first level of recognition. It acknowledges program participation and entry of baseline data into the 注册表工具.
遵循指南 - AFIB Achievement Measures.
The different levels reflect the amount of time for which the hospital demonstrates performance at a minimum of 85% compliance.
- Bronze: recognizes performance of 90 consecutive days.
- Silver recognizes performance of 12 consecutive months.
- Gold recognizes performance of 24 consecutive months or more.
Download 识别条件 for 遵循指南 - AFib
The Achievement Measures are embedded in the 注册表工具. 它们是:
- ACEI/ARB or ARNI Prescribed Prior to Discharge (When LVEF ≤40): Percentage of patients with a diagnosis of AF or atrial flutter, LVEF≤40的HF, 谁被开了ACEI, ARB or ARNI prior to discharge.
- CHA2DS2–VASc risk Score Documented Prior to Discharge:患者百分比, 18岁及以上, 与非瓣膜性 and bioprosthetic valve Atrial Fibrillation or Atrial Flutter for in whom assessment of thromboembolic risk factors using the CHA2DS2- VASc risk score criteria has been documented in the medical record.
- Beta Blocker Prescribed Prior to Discharge (when LVEF ≤ 40):患者百分比, 年龄≥18岁, with a diagnosis of AF or atrial flutter with an LVEF ≤40 who were prescribed a beta blocker prior to discharge.
- FDA approved Anticoagulation Prescribed Prior to Discharge:患者百分比, 18岁及以上, 与非瓣膜性, valvular and bioprosthetic valve atrial fibrillation or atrial flutter who were discharged on warfarin or another Food and Drug Administration (FDA) approved other anticoagulant drug that is FDA approved for the prevention of thromboembolism for all patients 与非瓣膜性, valvular and bioprosthetic valve atrial fibrillation or atrial flutter at high risk for thromboembolism, according to CHA2DS2–VASc risk stratification.
- PT/INR Planned Follow-Up Documented Prior to Discharge for Warfarin Treatment:患者百分比, 年龄≥18岁, 与非瓣膜性, valvular and bioprosthetic valve AF or atrial flutter who have been prescribed warfarin and who have a PT/INR follow-up scheduled prior to hospital discharge.
- Statin at discharge in AF patients with CAD, 患者/ TIA, PVD, or Diabetes:患者百分比 with either CAD, 患者/ TIA, PVD or diabetes who were prescribed a statin at hospital discharge.
We thank you for your continued dedication to improving patient care, if you have any questions please contact your 当地代表 或电子邮件 (电子邮件保护).
请注意: 识别 criteria are subject to change based on program enhancements
![心脏节律学会](/-/media/Images/Professional/Quality-Improvement/HRS-logo-236x475-web9.jpg?h=475&iar=0&mw=390&w=236)
Working Together to Advance Cardiovascular Research and Guideline Implementation
Collaborating with the 心脏节律学会 brings the expertise of the largest U.S. electrophysiology professional organization together with the 美国心脏协会's leadership in improving healthcare quality.